March 14, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Merck KGaA, Darmstadt, Germany, Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology

Darmstadt, Germany, March 14, 2019 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of... Read more

March 12, 2019 Clinical Research/Diagn. M&A, Partnerships

The Netherlands Cancer Institute (NKI) selects Labguru to further pioneering cancer research and treatment

NKI completes institute wide adoption of Labguru to increase efficiency and maximize productivity in the laboratory 12 March 2019, Cambridge, MA: BioData has announced The Netherlands Cancer Institute (NKI) has started an institute wide deployment of its flagship product Labguru. NKI has secured an institutional licence of Labguru’s Electronic Lab Notebook (ELN) for further collaboration across... Read more

March 12, 2019 Clinical Research/Diagn. M&A, Partnerships

Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model

San Diego, Calif. and Wilmington, Mass. – March 12, 2019 – Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced a licensing agreement with Charles River Laboratories International, Inc.’s Research Models and Services business. The agreement, designed to expand access to... Read more

March 11, 2019 Clinical Research/Diagn. Informatics & Software Life Science Tools Product Launch

DNAnexus Introduces Innovative Clinico-Genomic Browser to Allow Diverse Research Teams to Explore Complex Human Data Sets

The Regeneron Genetics Center successfully deployed the cohort browser against a large genomic and phenotypic UK Biobank data set March 11, 2019 09:15 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™... Read more

March 11, 2019 Clinical Research/Diagn.

Roche’s VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq in combination with Abraxane

Basel, 11 March 2019 Roche’s VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq in combination with Abraxane PD-L1 (SP142) was the enrollment assay used in the IMpassion130 trial, the first positive phase III immunotherapy regimen study in triple-negative breast cancer Each year about... Read more

March 7, 2019 Clinical Research/Diagn. Life Science Tools

Novel enzyme from LGC, Biosearch Technologies is fast and specific, even at room temperature

LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase (RT) designed specifically to meet the needs of diagnostic kit developers.   This reverse transcriptase has a temperature optimum from 55 – 80 °C, improving reaction specificity and allowing synthesis from diverse RNA templates.  It is also fast, with a reaction time of five... Read more

March 5, 2019 Clinical Research/Diagn. PR/Corporate

Bio-Techne Scores a Trio of CiteAb 2019 Awards

MARCH 05, 2019 MINNEAPOLIS, March 5, 2019 /PRNewswire/ — Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, was honored with three prestigious 2019 CiteAb Awards. The CiteAb Awards celebrate the very best suppliers and individuals in the research sector worldwide.  Bio-Techne’s Advanced Cell Diagnostics (ACD) brand received... Read more

March 1, 2019 Clinical Research/Diagn. M&A, Partnerships

Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse

Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Obesity, and Metabolic Disease Platform San Diego, Calif. – March 5, 2019 – Crown Bioscience, a global drug discovery and development services company, providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced... Read more

February 28, 2019 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle Inc.

Indianapolis, Indiana (February 28, 2019) – At the Advances in Genome Biology and Technology (AGBT) General Meeting*, Beckman Coulter Life Sciences announces the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company. As cfDNA workflows move beyond theoretical and into human health applications, Apostle’s industry leading chemistry... Read more

February 26, 2019 Clinical Research/Diagn. M&A, Partnerships

Bio-Techne Signs Strategic Cooperation Agreement With Lisen Imprinting Diagnostics

FEBRUARY 26, 2019 MINNEAPOLIS, Feb. 26, 2019 /PRNewswire/ — Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co., Ltd, China. Liwen Pei, Managing Director of Bio-Techne China, and Ning Zhou, CEO of Lisen, attended the meeting and signing ceremony. Bio-Techne is a leading provider of high-quality... Read more